Skip to content
About
The Shackelford Story
Leadership
Newsroom
News Releases
Interviews & Appearances
Dr. Shackelford’s Availability
Patients
Orphan Strategy
Investors
Pipeline
About
The Shackelford Story
Leadership
Newsroom
News Releases
Interviews & Appearances
Dr. Shackelford’s Availability
Patients
Orphan Strategy
Investors
Pipeline
About
The Shackelford Story
Leadership
Newsroom
News Releases
Interviews & Appearances
Dr. Shackelford’s Availability
Patients
Orphan Strategy
Investors
Pipeline
About
The Shackelford Story
Leadership
Newsroom
News Releases
Interviews & Appearances
Dr. Shackelford’s Availability
Patients
Orphan Strategy
Investors
Pipeline
INVEST
News Releases
Shackelford Pharma Inc. Confirms Three Human Phase 2 Trials on Track to Begin in 2021 and Announces March 31st Closing Date for Regulation A+ Offering
March 13, 2021
Read More
Charlotte Figi Day in Colorado: April 7th
February 22, 2021
Read More
Forbes Article on Dr. Shackelford
December 15, 2020
Read More
Honoring Charlotte Figi
April 9, 2020
Read More
Invest in Shackelford
Shackelford Pharma’s Regulation A Financing is now open. Investors are required to fill out the form below to begin the investment process.
Please check your JUNK/SPAM email folder if your invitation email from Dealmaker/Shackelford does not arrive in your inbox.
Invest Shackelford
FIRST NAME
*
First
LAST NAME
Last
PHONE NUMBER
*
EMAIL
*
